Search by Drug Name or NDC
NDC 71403-0003-30 Rhofade 1 g/100g Details
Rhofade 1 g/100g
Rhofade is a TOPICAL CREAM in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by EPI Health, LLC. The primary component is OXYMETAZOLINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Oxymetazoline is used to treat ongoing facial redness caused by rosacea (a skin disease that causes redness and pimples on the face). Oxymetazoline is in a class of medications called alpha1A adrenoceptor agonists. It works by narrowing the blood vessels in the skin.
Related Packages: 71403-0003-30Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Oxymetazoline Topical
Product Information
| NDC | 71403-0003 |
|---|---|
| Product ID | 71403-003_d743c06d-1277-4504-803b-5752af09ba03 |
| Associated GPIs | 90060050103720 |
| GCN Sequence Number | 077067 |
| GCN Sequence Number Description | oxymetazoline HCl CREAM (G) 1 % TOPICAL |
| HIC3 | L5G |
| HIC3 Description | ROSACEA AGENTS, TOPICAL |
| GCN | 42948 |
| HICL Sequence Number | 003417 |
| HICL Sequence Number Description | OXYMETAZOLINE HCL |
| Brand/Generic | Brand |
| Proprietary Name | Rhofade |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | OXYMETAZOLINE HYDROCHLORIDE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CREAM |
| Route | TOPICAL |
| Active Ingredient Strength | 1 |
| Active Ingredient Units | g/100g |
| Substance Name | OXYMETAZOLINE HYDROCHLORIDE |
| Labeler Name | EPI Health, LLC |
| Pharmaceutical Class | Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA208552 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 71403-0003-30 (71403000330)
| NDC Package Code | 71403-003-30 |
|---|---|
| Billing NDC | 71403000330 |
| Package | 1 TUBE in 1 CARTON (71403-003-30) / 30 g in 1 TUBE |
| Marketing Start Date | 2021-01-18 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 19.738 |
| Pricing Unit | GM |
| Effective Date | 2023-09-20 |
| NDC Description | RHOFADE 1% CREAM |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 2, 5 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis